On April 21, 2025, Beneficient announced the completion of a primary capital transaction, exchanging a limited partner interest valued at $233,333 for 23,333 shares of Series B-7 Resettable Convertible Preferred Stock, convertible to Class A Common Stock at a price starting at $0.2979 per share.